The Diverticular Disease Registry (DDR Trial) by the Advanced International Mini-Invasive Surgery Academy Clinical Research Network: Protocol for a Multicenter, Prospective Observational Study.

IF 16.4 1区 化学 Q1 CHEMISTRY, MULTIDISCIPLINARY
Accounts of Chemical Research Pub Date : 2021-08-30 eCollection Date: 2021-01-01 DOI:10.29337/ijsp.157
Matteo Origi, Pietro Achilli, Giacomo Calini, Andrea Costanzi, Michela Monteleone, Isacco Montroni, Dario Maggioni, Eugenio Cocozza, Stefano Megna, Mauro Totis, Nicolo' Tamini, Antonio Ziccarelli, Gaetano Filippone, Giovanni Ferrari, Jacopo Crippa, Antonino Spinelli, Giulio M Mari
{"title":"The Diverticular Disease Registry (DDR Trial) by the Advanced International Mini-Invasive Surgery Academy Clinical Research Network: Protocol for a Multicenter, Prospective Observational Study.","authors":"Matteo Origi,&nbsp;Pietro Achilli,&nbsp;Giacomo Calini,&nbsp;Andrea Costanzi,&nbsp;Michela Monteleone,&nbsp;Isacco Montroni,&nbsp;Dario Maggioni,&nbsp;Eugenio Cocozza,&nbsp;Stefano Megna,&nbsp;Mauro Totis,&nbsp;Nicolo' Tamini,&nbsp;Antonio Ziccarelli,&nbsp;Gaetano Filippone,&nbsp;Giovanni Ferrari,&nbsp;Jacopo Crippa,&nbsp;Antonino Spinelli,&nbsp;Giulio M Mari","doi":"10.29337/ijsp.157","DOIUrl":null,"url":null,"abstract":"<p><p>Diverticular disease is an increasingly common issue, with a variety of clinical presentations and treatment options. However, very few prospective cohort studies explore outcomes between the different presentations and treatments. The Diverticular Disease Registry (DDR Trial) is a multicenter, prospective, observational cohort study on behalf of the Advanced International Mini-Invasive Surgery (AIMS) academy clinical research network. The DDR Trial aims to investigate the short-term postoperative and long-term quality of life outcomes in patients undergoing surgery or medical treatments for diverticular disease. DDR Trial is open to participation by all tertiary-care hospitals. DDR Trial has been registered at ClinicalTrials.gov (NCT04907383). Data collection will be recorded on Research Electronic Data Capture (REDCap) starting on June 1<sup>st</sup>, 2021 and will end after 5 years of recruitment. All adult patients with imaging-proven colonic diverticular disease (i.e., symptomatic colonic diverticulosis including diverticular bleeding, diverticulitis, and Symptomatic Uncomplicated Diverticular Disease) will be included. The primary outcome of DDR Trial is quality of life assessment at 12-month according to the Gastrointestinal Quality of Life Index (GIQLI). The secondary outcome is 30-day postoperative outcomes according to the Clavien-Dindo classification. DDR Trial will significantly advance in identifying the optimal care for patients with diverticular disease by exploring outcomes of different presentations and treatments.</p><p><strong>Highlights: </strong>Diverticular disease (i.e., diverticulitis, bleeding) has different treatments.This is a clinical protocol for the Diverticular Disease Registry (DDR Trial).DDR Trial is a multicenter, prospective, observational cohort study open to participation.DDR Trial will study short-term postoperative and long-term quality of life outcomes.Medical treatments, interventional radiology and surgery will be explored.</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2021-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415185/pdf/","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.29337/ijsp.157","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 3

Abstract

Diverticular disease is an increasingly common issue, with a variety of clinical presentations and treatment options. However, very few prospective cohort studies explore outcomes between the different presentations and treatments. The Diverticular Disease Registry (DDR Trial) is a multicenter, prospective, observational cohort study on behalf of the Advanced International Mini-Invasive Surgery (AIMS) academy clinical research network. The DDR Trial aims to investigate the short-term postoperative and long-term quality of life outcomes in patients undergoing surgery or medical treatments for diverticular disease. DDR Trial is open to participation by all tertiary-care hospitals. DDR Trial has been registered at ClinicalTrials.gov (NCT04907383). Data collection will be recorded on Research Electronic Data Capture (REDCap) starting on June 1st, 2021 and will end after 5 years of recruitment. All adult patients with imaging-proven colonic diverticular disease (i.e., symptomatic colonic diverticulosis including diverticular bleeding, diverticulitis, and Symptomatic Uncomplicated Diverticular Disease) will be included. The primary outcome of DDR Trial is quality of life assessment at 12-month according to the Gastrointestinal Quality of Life Index (GIQLI). The secondary outcome is 30-day postoperative outcomes according to the Clavien-Dindo classification. DDR Trial will significantly advance in identifying the optimal care for patients with diverticular disease by exploring outcomes of different presentations and treatments.

Highlights: Diverticular disease (i.e., diverticulitis, bleeding) has different treatments.This is a clinical protocol for the Diverticular Disease Registry (DDR Trial).DDR Trial is a multicenter, prospective, observational cohort study open to participation.DDR Trial will study short-term postoperative and long-term quality of life outcomes.Medical treatments, interventional radiology and surgery will be explored.

由先进国际微创外科学会临床研究网络进行的憩室疾病登记(DDR试验):一项多中心、前瞻性观察性研究方案。
憩室疾病是一个越来越常见的问题,有各种临床表现和治疗方案。然而,很少有前瞻性队列研究探讨不同表现和治疗之间的结果。憩室疾病登记(DDR试验)是代表先进国际微创外科(AIMS)学会临床研究网络进行的一项多中心、前瞻性、观察性队列研究。DDR试验旨在调查憩室疾病手术或药物治疗患者的短期术后和长期生活质量结果。DDR试验向所有三级保健医院开放。DDR试验已在ClinicalTrials.gov注册(NCT04907383)。数据收集将于2021年6月1日开始记录在研究电子数据采集(REDCap)上,并于招聘5年后结束。所有影像学证实的结肠憩室疾病(即症状性结肠憩室病,包括憩室出血、憩室炎和症状性无并发症憩室病)的成年患者将被纳入研究范围。DDR试验的主要终点是12个月时根据胃肠道生活质量指数(GIQLI)评估患者的生活质量。根据Clavien-Dindo分类,次要结果是术后30天的结果。DDR试验将通过探索不同表现和治疗的结果,在确定憩室疾病患者的最佳护理方面取得显著进展。重点:憩室疾病(如憩室炎、出血)有不同的治疗方法。这是憩室疾病登记(DDR试验)的临床方案。DDR试验是一项开放参与的多中心、前瞻性、观察性队列研究。DDR试验将研究术后短期和长期生活质量结果。将探索医学治疗、介入放射学和外科。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Accounts of Chemical Research
Accounts of Chemical Research 化学-化学综合
CiteScore
31.40
自引率
1.10%
发文量
312
审稿时长
2 months
期刊介绍: Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信